Friday, November 8, 2019

Strides Pharma relaunches Ranitidine tablets in US

Strides Pharma relaunches Ranitidine tablets in US The company had suspended sales of its generic Ranitidine tablets after the US Food and Drug Administration (USFDA) found contamination in some Ranitidine tablets sold by various companies with potentially cancer causing impurities, NDMA.

from Moneycontrol Business News https://ift.tt/32qJ21Z

No comments:

Post a Comment

Bulls return to D-Street as falling oil prices ease geopolitical jitters

Indian stock markets experienced a significant rally on Wednesday. Both the Nifty 50 and S&P BSE Sensex saw gains exceeding 1 percent. T...